CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in JNJ — Johnson & Johnson
CIK 884546
SAN FRANCISCO, CA
Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,687,679,411
+$748,530,613 QoQ
Shares Held
19,177,219
+0.8% QoQ
Ownership
0.797%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.06897345230297.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9310265476970357.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. JNJ ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,687,679,411 | 19,177,219 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,939,148,798 | 19,034,302 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $3,525,215,978 | 19,012,059 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,894,816,725 | 18,951,337 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,131,692,708 | 18,883,820 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,630,215,797 | 18,187,082 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,858,635,977 | 17,639,368 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,563,188,333 | 17,536,866 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $2,559,187,062 | 16,177,932 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,499,302,842 | 15,945,533 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $2,445,856,569 | 15,703,734 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,834,246,132 | 17,123,285 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,657,679,445 | 17,146,319 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,018,342,766 | 17,086,571 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,762,753,304 | 16,912,055 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,941,039,464 | 16,568,303 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,046,447,055 | 17,189,229 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,884,399,637 | 16,860,932 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,653,370,387 | 16,429,538 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,677,582,315 | 16,253,383 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,612,684,604 | 15,897,077 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,466,871,695 | 15,674,620 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,328,062,316 | 15,637,173 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,309,800,357 | 16,424,663 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,172,872,224 | 16,570,367 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||